Anticancer activity of 4'-phenyl-2,2':6',2″-terpyridines - behind the metal complexation.

[1]  A. R. Fernandes,et al.  Copper(ii) complexes with 2,2':6',2''-terpyridine, 2,6-di(thiazol-2-yl)pyridine and 2,6-di(pyrazin-2-yl)pyridine substituted with quinolines. Synthesis, structure, antiproliferative activity, and catalytic activity in the oxidation of alkanes and alcohols with peroxides. , 2019, Dalton transactions.

[2]  J. Polanski,et al.  Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety. , 2019, European journal of medicinal chemistry.

[3]  R. Musioł,et al.  4′-Phenyl-2,2′:6′,2′′-terpyridine Derivatives Containing 1-Substituted-2,3-Triazole Ring: Synthesis, Characterization and Anticancer Activity , 2018, ChemistrySelect.

[4]  J. Polanski,et al.  Piperazinyl fragment improves anticancer activity of Triapine , 2018, PloS one.

[5]  J. Polanski,et al.  The role of oxidative stress in activity of anticancer thiosemicarbazones , 2018, Oncotarget.

[6]  D. Mahendiran,et al.  Heteroleptic silver(I) complexes with 2,2':6',2″-terpyridines and naproxen: DNA interaction, EGFR/VEGFR2 kinase, growth inhibition and cell cycle arrest studies. , 2017, Materials science & engineering. C, Materials for biological applications.

[7]  S. Radulović,et al.  New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies. , 2017, Journal of inorganic biochemistry.

[8]  Sasanka Deka,et al.  Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity. , 2017, Dalton transactions.

[9]  D. Averill-Bates,et al.  Activation of apoptosis signalling pathways by reactive oxygen species. , 2016, Biochimica et biophysica acta.

[10]  A. Shahpiri,et al.  A water-soluble Pd(II) complex with a terpyridine ligand: experimental and molecular modeling studies of the interaction with DNA and BSA; and in vitro cytotoxicity investigations against five human cancer cell lines , 2016 .

[11]  U. Schubert,et al.  Iridium(III) Complexes of Terpyridine‐ and Terpyridine‐Analogous Ligands Bearing Sugar Residues and Their in vitro Activity , 2016 .

[12]  D. Velmurugan,et al.  Targeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes. , 2016, Dalton transactions.

[13]  G. Viscardi,et al.  Terpyridine and Quaterpyridine Complexes as Sensitizers for Photovoltaic Applications , 2016, Materials.

[14]  DUOBIN CHAO,et al.  Highly selective detection of Zn2+ and Cd2+ with a simple amino-terpyridine compound in solution and solid state , 2016, Journal of Chemical Sciences.

[15]  M. Giustini,et al.  Interaction of Cd(II) and Ni(II) terpyridine complexes with model polynucleotides: a multidisciplinary approach , 2016 .

[16]  V. Kryštof,et al.  Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action , 2015, PloS one.

[17]  Delphine Denoyer,et al.  Targeting copper in cancer therapy: 'Copper That Cancer'. , 2015, Metallomics : integrated biometal science.

[18]  R. Pérez-Tomás,et al.  The effect of potential supramolecular-bond promoters on the DNA-interacting abilities of copper-terpyridine compounds. , 2015, Dalton transactions.

[19]  N. Chandel,et al.  ROS-dependent signal transduction. , 2015, Current opinion in cell biology.

[20]  J. Aldrich-Wright,et al.  Metal complex interactions with DNA. , 2015, Dalton transactions.

[21]  Guanying Li,et al.  Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives. , 2014, Journal of inorganic biochemistry.

[22]  M. Giel-Pietraszuk,et al.  6,6″-Dimethyl-2,2':6',2″-terpyridine revisited: new fluorescent silver(I) helicates with in vitro antiproliferative activity via selective nucleoli targeting. , 2014, European journal of medicinal chemistry.

[23]  J. Gołąb,et al.  Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships , 2014, PloS one.

[24]  V. Yilmaz,et al.  Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo. , 2014, Bioorganic & medicinal chemistry.

[25]  T. Najam,et al.  DNA binding mode of transition metal complexes, a relationship to tumor cell toxicity. , 2014, Current medicinal chemistry.

[26]  Dirk G Kurth,et al.  From terpyridine-based assemblies to metallo-supramolecular polyelectrolytes (MEPEs). , 2014, Advances in colloid and interface science.

[27]  G. Kharadi.  Effect of substituent of terpyridines on the in vitro antioxidant, antitubercular, biocidal and fluorescence studies of copper(II) complexes with clioquinol. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[28]  B. Unni Nair,et al.  DNA binding and cytotoxicity of copper (II) imidazole terpyridine complexes: role of oxyanion, hydrogen bonding and π-π interaction. , 2013, European journal of medicinal chemistry.

[29]  B. Nair,et al.  Effect of coordinated ligands on antiproliferative activity and DNA cleavage property of three mononuclear Cu(II)-terpyridine complexes. , 2012, European journal of medicinal chemistry.

[30]  M. Hager,et al.  The Marriage of Terpyridines and Inorganic Nanoparticles: Synthetic Aspects, Characterization Techniques, and Potential Applications , 2011, Advanced materials.

[31]  L. Saghatforoush,et al.  Synthesis, Characterization, Crystal Structure, and Biological Studies of a Cadmium(II) Complex with a Tridentate Ligand 4′-Chloro-2,2′:6′,2′′-Terpyridine , 2011, Bioinorganic chemistry and applications.

[32]  M. Rigoulet,et al.  Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. , 2011, Antioxidants & redox signaling.

[33]  D. Richardson,et al.  Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. , 2009, Journal of medicinal chemistry.

[34]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[35]  U. Schubert,et al.  Azido- and Ethynyl-Substituted 2,2¢:6¢,2¢¢-Terpyridines as Suitable Substrates for Click Reactions , 2009 .

[36]  S. Balasubramanian,et al.  Synthesis, characterization and electrochemistry of 4'-functionalized 2,2':6',2''-terpyridine ruthenium(II) complexes and their biological activity. , 2008, Dalton transactions.

[37]  D. Richardson,et al.  Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. , 2007, Blood.

[38]  Harald Hofmeier,et al.  Recent developments in the supramolecular chemistry of terpyridine-metal complexes. , 2004, Chemical Society reviews.

[39]  J. M. Pratt,et al.  Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma. , 1999, Journal of medicinal chemistry.

[40]  C. Leung,et al.  Recent development of transition metal complexes with in vivo antitumor activity. , 2017, Journal of inorganic biochemistry.

[41]  F. Pruchnik,et al.  Properties of Binuclear Rhodium(II) Complexes and Their Antibacterial Activity , 1996, Metal-based drugs.